ResMed (RMD) Competitors $245.49 -0.29 (-0.12%) Closing price 03:59 PM EasternExtended Trading$245.48 -0.01 (0.00%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RMD vs. MDT, BDX, EW, IDXX, DXCM, STE, PODD, BAX, HOLX, and MASIShould you be buying ResMed stock or one of its competitors? The main competitors of ResMed include Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), and Masimo (MASI). These companies are all part of the "health care equipment" industry. ResMed vs. Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories DexCom STERIS Insulet Baxter International Hologic Masimo ResMed (NYSE:RMD) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, community ranking, analyst recommendations, earnings, risk, profitability and media sentiment. Does the MarketBeat Community prefer RMD or MDT? Medtronic received 1153 more outperform votes than ResMed when rated by MarketBeat users. Likewise, 75.40% of users gave Medtronic an outperform vote while only 52.71% of users gave ResMed an outperform vote. CompanyUnderperformOutperformResMedOutperform Votes43852.71% Underperform Votes39347.29% MedtronicOutperform Votes159175.40% Underperform Votes51924.60% Do analysts rate RMD or MDT? ResMed presently has a consensus price target of $258.83, indicating a potential upside of 5.44%. Medtronic has a consensus price target of $96.07, indicating a potential upside of 18.70%. Given Medtronic's higher probable upside, analysts clearly believe Medtronic is more favorable than ResMed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ResMed 1 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.60Medtronic 1 Sell rating(s) 8 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.47 Is RMD or MDT more profitable? ResMed has a net margin of 25.34% compared to Medtronic's net margin of 12.83%. ResMed's return on equity of 26.17% beat Medtronic's return on equity.Company Net Margins Return on Equity Return on Assets ResMed25.34% 26.17% 18.60% Medtronic 12.83%14.07%7.70% Do institutionals and insiders have more ownership in RMD or MDT? 55.0% of ResMed shares are held by institutional investors. Comparatively, 82.1% of Medtronic shares are held by institutional investors. 0.7% of ResMed shares are held by insiders. Comparatively, 0.2% of Medtronic shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is RMD or MDT a better dividend stock? ResMed pays an annual dividend of $2.12 per share and has a dividend yield of 0.9%. Medtronic pays an annual dividend of $2.80 per share and has a dividend yield of 3.5%. ResMed pays out 23.8% of its earnings in the form of a dividend. Medtronic pays out 85.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. ResMed has raised its dividend for 13 consecutive years and Medtronic has raised its dividend for 48 consecutive years. Medtronic is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Does the media refer more to RMD or MDT? In the previous week, Medtronic had 26 more articles in the media than ResMed. MarketBeat recorded 68 mentions for Medtronic and 42 mentions for ResMed. ResMed's average media sentiment score of 1.22 beat Medtronic's score of 0.83 indicating that ResMed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ResMed 31 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medtronic 32 Very Positive mention(s) 5 Positive mention(s) 20 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, RMD or MDT? Medtronic has higher revenue and earnings than ResMed. Medtronic is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioResMed$5.02B7.17$1.02B$8.9127.55Medtronic$33.20B3.13$3.68B$3.2924.60 Which has more risk and volatility, RMD or MDT? ResMed has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. SummaryResMed beats Medtronic on 11 of the 21 factors compared between the two stocks. Get ResMed News Delivered to You Automatically Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RMD vs. The Competition Export to ExcelMetricResMedSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$36.00B$4.43B$5.33B$19.30BDividend Yield0.84%43.63%5.21%3.84%P/E Ratio28.9829.0826.7134.53Price / Sales7.1766.76386.1334.83Price / Cash25.2351.0838.2517.51Price / Book6.866.196.774.69Net Income$1.02B$67.60M$3.23B$1.02B7 Day Performance-1.25%-0.63%1.80%-1.74%1 Month Performance14.50%17.91%11.10%7.50%1 Year Performance12.47%21.16%17.11%4.15% ResMed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RMDResMed4.1128 of 5 stars$245.49-0.1%$258.83+5.4%+12.5%$36.00B$5.02B28.988,160Positive NewsInsider TradeAnalyst RevisionMDTMedtronic4.7737 of 5 stars$86.78+0.4%$96.14+10.8%-0.8%$111.30B$33.20B26.3895,000Trending NewsEarnings ReportDividend IncreaseAnalyst ForecastOptions VolumeBDXBecton, Dickinson and Company4.9803 of 5 stars$176.33+0.5%$231.44+31.3%-26.2%$50.54B$20.87B29.2977,000Positive NewsAnalyst ForecastEWEdwards Lifesciences4.3624 of 5 stars$77.980.0%$79.60+2.1%-15.7%$45.74B$5.52B11.1917,300Positive NewsAnalyst ForecastInsider TradeIDXXIDEXX Laboratories3.4005 of 5 stars$519.35+0.2%$536.00+3.2%-3.4%$41.77B$3.93B48.6710,800News CoveragePositive NewsAnalyst ForecastDXCMDexCom4.7397 of 5 stars$86.72+1.5%$98.11+13.1%-35.1%$34.00B$4.15B60.647,600Positive NewsAnalyst ForecastSTESTERIS4.5557 of 5 stars$251.480.0%$264.00+5.0%+6.8%$24.71B$5.40B53.3916,000News CoverageAnalyst ForecastPODDInsulet4.4384 of 5 stars$325.30+0.2%$306.53-5.8%+77.5%$22.89B$2.20B56.182,600Positive NewsAnalyst ForecastBAXBaxter International4.6541 of 5 stars$31.36-0.9%$37.25+18.8%-11.7%$16.09B$10.77B-24.5060,000HOLXHologic4.9554 of 5 stars$56.29-0.9%$77.42+37.5%-26.5%$12.54B$4.03B17.766,940Positive NewsMASIMasimo4.8502 of 5 stars$154.54-0.7%$191.60+24.0%+20.0%$8.38B$2.13B106.586,200Positive News Related Companies and Tools Related Companies Medtronic Competitors Becton, Dickinson and Company Competitors Edwards Lifesciences Competitors IDEXX Laboratories Competitors DexCom Competitors STERIS Competitors Insulet Competitors Baxter International Competitors Hologic Competitors Masimo Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RMD) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ResMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.